What is the impact factor of Seminars in Liver Disease?

7.3. The 2022 impact factor of Seminars in Liver Disease is 7.3. By the impact factor, Seminars in Liver Disease falls within the top 1% of scholarly journals.

Seminars in Liver Disease Top Articles: scientometric...

7.3(top 1%)

Impact Factor

7.8(top 1%)

extended IF

137(top 2%)

H-Index

400

authors

1.6K

papers

96.6K

citations

5.3K

citing journals

33.6K

citing authors

Most Cited Articles of Seminars in Liver Disease

Title	Year	Citations
Prognosis of hepatocellular carcinoma: the BCLC staging classification	1999	2.7K
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma	2010	2.5K
The epidemiology of cholangiocarcinoma	2004	912
Macrophages: master regulators of inflammation and fibrosis	2010	878
Resection and liver transplantation for hepatocellular carcinoma	2005	878
Current strategy for staging and treatment: the BCLC update and future prospects	2010	770
Epidemiology of primary liver cancer	1999	763
Epidemiology of hepatitis C: geographic differences and temporal trends	2000	704
Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes	1995	643
Nonalcoholic steatohepatitis: definition and pathology	2001	630
Pharmacological treatment of portal hypertension: an evidence-based approach	1999	608
Overview of microRNA biology	2015	584
Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome	2000	562
History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells	2001	558
The epidemiology of nonalcoholic fatty liver disease: a global perspective	2008	547
Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease)	2002	477
Fulminant and subfulminant liver failure: definitions and causes	1986	477
Etiopathogenesis of nonalcoholic steatohepatitis	2001	467
Genomics and signaling pathways in hepatocellular carcinoma	2007	425
Clinical features and natural history of nonalcoholic steatosis syndromes	2001	418
Matrix as a modulator of hepatic fibrogenesis	2001	404
Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease	2008	393
Extracellular matrix degradation and the role of hepatic stellate cells	2001	393
Bacterial infections, sepsis, and multiorgan failure in cirrhosis	2008	388
Hepatic stellate cells as a target for the treatment of liver fibrosis	2001	388

0 1 2 next

How are inpact factors calculated?

The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.

extended IF also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.

Scientometrics

Overviews

Seminars in Liver Disease

Hepatology

Most Cited Articles of Seminars in Liver Disease